Skandinaviska Enskilda Banken (SEB)’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,711
Closed -$483K 1000
2023
Q2
$483K Hold
2,711
﹤0.01% 791
2023
Q1
$584K Sell
2,711
-2,467
-48% -$592K ﹤0.01% 758
2022
Q4
$1.14M Sell
5,178
-5,299
-51% -$972K 0.01% 654
2022
Q3
$1.41M Hold
10,477
0.01% 612
2022
Q2
$1.7M Hold
10,477
0.01% 612
2022
Q1
$1.98M Sell
10,477
-852
-8% -$181K 0.01% 629
2021
Q4
$3.1M Hold
11,329
0.02% 539
2021
Q3
$4.11M Sell
11,329
-4,003
-26% -$1.31M 0.02% 461
2021
Q2
$5.26M Buy
15,332
+4,196
+38% +$1.39M 0.03% 411
2021
Q1
$3.88M Buy
11,136
+4,536
+69% +$1.5M 0.03% 454
2020
Q4
$1.71M Buy
6,600
+1,300
+25% +$358K 0.01% 699
2020
Q3
$1.52M Buy
5,300
+100
+2% +$23.5K 0.01% 652
2020
Q2
$980K Hold
5,200
0.01% 727
2020
Q1
$640K Buy
5,200
+200
+4% +$31.3K 0.01% 717
2019
Q4
$829K Buy
5,000
+2,972
+147% +$494K 0.01% 748
2019
Q3
$248K Buy
2,028
+400
+25% +$53.1K ﹤0.01% 837
2019
Q2
$202K Buy
+1,628
New +$207K ﹤0.01% 775

Other funds holding ONC

Skandinaviska Enskilda Banken (SEB)'s ONC Position: Q3 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of BeOne Medicines Ltd (ONC) in Q3 2023, closing a stake of 2,711 shares — an estimated $483K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ONC in Q2 2019 and held it in 17 quarters. The position peaked at $5.26M in Q2 2021. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining BeOne Medicines Ltd position as of Q3 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 2,711 BeOne Medicines Ltd shares in Q3 2023, an estimated $483K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 17 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s BeOne Medicines Ltd position peaked at $5.26M in Q2 2021.
  • 201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2023, filed 9 Nov 2023.